F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Liver fibrosis

Page 1 of 6 ( 270 items )
<<
1
2
3
4
5
6
>>

1	Accuracy of non-invasive tests for diagnosing liver fibrosis and steatosis: A systematic review 9/8/2026 3:16:27 AM \| Browse: 34 \| Download: 93
2	Suppression of the STAT3/MYC/MCL-1 pathway by the fixed Jianpi Huoxue Formula relieves early biochemical abnormalities in liver fibrosis 8/18/2026 3:51:53 AM \| Browse: 49 \| Download: 215
3	Echoes of ancient wisdom and synergistic strategies invigorate the fight against liver fibrosis 6/30/2026 1:40:20 PM \| Browse: 83 \| Download: 310
4	Adipokine profiles reflect metabolic dysfunction but not fibrosis in patients with primary biliary cholangitis 2/12/2026 11:20:21 AM \| Browse: 161 \| Download: 767
5	Levodopa: A novel therapeutic prospect for liver disease 2/12/2026 11:20:20 AM \| Browse: 290 \| Download: 508
6	Should the theory of methotrexate-induced liver toxicity be abandoned? 2/12/2026 11:20:20 AM \| Browse: 246 \| Download: 519
7	Noninvasive liver fibrosis assessment in metabolic dysfunction-associated steatotic liver disease 1/27/2026 10:12:30 AM \| Browse: 264 \| Download: 386
8	Chrono-optimal treatments for human immunodeficiency virus/hepatitis C virus co-infection yield comparable survival outcomes with hepatitis C virus mono-infection 1/16/2026 11:31:19 AM \| Browse: 171 \| Download: 737
9	He-He-Shu-Yang formula alleviates liver fibrosis by inhibiting hepatic stellate cell activation in vivo and in vitro 12/26/2025 10:27:30 AM \| Browse: 172 \| Download: 619
10	Saffron and Calculus bovis combination exerts anti-hepatic fibrotic effect in liver fibrosis rats via the mitogen-activated protein kinases pathway 12/19/2025 10:39:43 AM \| Browse: 167 \| Download: 612
11	Advances in endoscopic ultrasound-guided shear wave elastography: A comprehensive review of its clinical applications 12/10/2025 7:48:07 AM \| Browse: 265 \| Download: 465
12	Levodopa and the dopamine receptor D1-Hippo/yes-associated protein axis: A novel therapeutic avenue for liver fibrosis 12/10/2025 7:48:07 AM \| Browse: 182 \| Download: 447
13	Non-invasive blood biomarkers for assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease 11/27/2025 7:53:54 AM \| Browse: 152 \| Download: 421
14	Real-world performance of transient elastography in assessing advanced fibrosis in Chinese patients with primary biliary cholangitis 11/6/2025 8:56:33 AM \| Browse: 261 \| Download: 856
15	Gray zone and the need for expansion in chronic hepatitis B: From theory to clinical practice 10/27/2025 10:57:50 AM \| Browse: 451 \| Download: 630
16	Nanoparticle-based systems for liver therapy: Overcoming fibrosis and enhancing drug efficacy 10/27/2025 10:57:49 AM \| Browse: 384 \| Download: 625
17	Revitalizing liver health: Human placental extract shows promise in chronic liver disease management 10/11/2025 9:30:02 AM \| Browse: 198 \| Download: 479
18	Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals 9/25/2025 11:24:03 AM \| Browse: 227 \| Download: 705
19	Machine learning fibrosis score for pediatric metabolic dysfunction-associated steatotic liver disease: Promising but premature 9/19/2025 7:57:22 AM \| Browse: 684 \| Download: 730
20	Dopamine receptor D1-mediated suppression of liver fibrosis via Hippo/Yes-associated protein 1 signaling in levodopa treatment 9/5/2025 6:36:19 AM \| Browse: 578 \| Download: 719
21	Dual therapy with vildagliptin and sacubitril/valsartan alleviates portal hypertension and inhibits soluble epoxide hydrolase in cirrhotic rats 9/1/2025 8:05:37 AM \| Browse: 726 \| Download: 758
22	Predictive value of core-fucosylated low-molecular-weight kininogen levels in patients with liver fibrosis: A prospective study 8/5/2025 8:25:49 AM \| Browse: 239 \| Download: 1049
23	Poor sleep and hepatic steatosis contribute to poorer quality of life in people with human immunodeficiency virus 8/5/2025 8:25:47 AM \| Browse: 323 \| Download: 883
24	Utility of splenic transient elastography in assessing for the presence of portal hypertension: A review 8/4/2025 12:11:34 PM \| Browse: 241 \| Download: 705
25	Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives 7/25/2025 12:09:44 PM \| Browse: 337 \| Download: 716
26	Role of mac-2 binding protein glycosylation isomer in predicting fibrosis in patients with metabolic dysfunction-associated steatotic liver disease 7/25/2025 12:09:41 PM \| Browse: 362 \| Download: 1008
27	FBP1 as a key regulator of focal adhesion kinase-mediated hepatic stellate cell activation: Multi-omics and experimental validation 7/24/2025 7:47:20 AM \| Browse: 334 \| Download: 887
28	Chronic hepatitis B with type 2 diabetes mellitus: Association between glycemic control and liver fibrosis 7/15/2025 8:26:32 AM \| Browse: 328 \| Download: 1063
29	Multiparametric ultrasound for non-invasive assessment of liver steatosis, fibrosis and inflammation in metabolic dysfunction-associated steatotic liver disease 7/4/2025 9:23:53 AM \| Browse: 331 \| Download: 947
30	Dietary ω-3 polyunsaturated fatty acid intake improves skeletal muscle mass in patients with metabolic dysfunction-associated fatty liver disease: A nationwide cross-sectional study 6/26/2025 7:27:57 AM \| Browse: 220 \| Download: 1076
31	Micro RNAs as a potential biomarker for predicting liver fibrosis severity in hepatitis C virus affected patients 6/23/2025 7:18:41 AM \| Browse: 376 \| Download: 1216
32	Advancing the diagnosis and treatment of metabolic-associated steatotic liver disease: The transformative role of artificial intelligence 6/6/2025 9:35:52 AM \| Browse: 161 \| Download: 700
33	Multi-parameter magnetic resonance imaging of zebularine in liver fibrosis treatment and calcineurin/NFAT3 mechanism 5/28/2025 7:32:59 AM \| Browse: 202 \| Download: 905
34	Sarcopenia and frailty: An in-depth analysis of the pathophysiology and effect on liver transplant candidates 5/27/2025 7:04:49 AM \| Browse: 361 \| Download: 773
35	Assessing the role of Mac-2 binding protein glycosylation isomer in the management of patients with chronic hepatitis B 5/27/2025 7:04:48 AM \| Browse: 394 \| Download: 1232
36	Quantification of Streptococcus salivarius using the digital polymerase chain reaction as a liver fibrosis marker 4/25/2025 8:23:06 AM \| Browse: 342 \| Download: 1059
37	Psoriasis, metabolic syndrome and methotrexate: Is this association suitable for a new subcategory in steatotic liver disease? 4/25/2025 8:23:02 AM \| Browse: 332 \| Download: 644
38	Global trends in artificial intelligence applications in liver disease over seventeen years 3/26/2025 4:06:51 AM \| Browse: 365 \| Download: 1254
39	Therapeutic potential of elafibranor in alcohol-associated liver disease: Insights into macrophage modulation and fibrosis reduction 3/5/2025 9:35:47 AM \| Browse: 234 \| Download: 711
40	Modern ultrasound techniques for diagnosing liver steatosis and fibrosis: A systematic review with a focus on biopsy comparison 2/20/2025 8:40:29 AM \| Browse: 256 \| Download: 904
41	Assessment of skeletal muscle alterations and circulating myokines in metabolic dysfunction-associated steatotic liver disease: A cross-sectional study 1/20/2025 7:38:55 AM \| Browse: 296 \| Download: 1054
42	Hepatitis B virus infection and metabolic dysfunction associated steatotic liver disease: Rising pandemic with complex interaction 1/6/2025 8:47:56 AM \| Browse: 262 \| Download: 752
43	Hotspots and trends in stem cell therapy for liver fibrosis and cirrhosis: A bibliometric analysis 1/6/2025 8:47:54 AM \| Browse: 275 \| Download: 1041
44	Elafibranor, a dual PPARα and PPARδ agonist, reduces alcohol-associated liver disease: Lessons from a mouse model 12/30/2024 6:47:30 AM \| Browse: 197 \| Download: 778
45	Red cell distribution width/platelet ratio predicts decompensation of metabolic dysfunction-associated steatotic liver disease related compensated advanced chronic liver disease 12/20/2024 3:53:49 AM \| Browse: 324 \| Download: 826
46	Elafibranor: A promising therapeutic approach for liver fibrosis and gut barrier dysfunction in alcohol-associated liver disease 12/20/2024 3:53:47 AM \| Browse: 389 \| Download: 839
47	Calculus bovis hijacks the tumor microenvironment in liver cancer cells in a multifaceted approach: A falling row of dominoes 11/29/2024 8:40:09 AM \| Browse: 249 \| Download: 1042
48	GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis 11/29/2024 8:40:08 AM \| Browse: 340 \| Download: 743
49	Elafibranor alleviates alcohol-related liver fibrosis by restoring intestinal barrier function 10/31/2024 10:42:49 AM \| Browse: 271 \| Download: 931
50	Encapsulating taurine into liposomes: A promising therapeutic for liver fibrosis 10/23/2024 4:32:16 AM \| Browse: 279 \| Download: 892

Page 1 of 6 ( 270 items )
<<
1
2
3
4
5
6
>>

1	Accuracy of non-invasive tests for diagnosing liver fibrosis and steatosis: A systematic review 9/8/2026 3:16:27 AM \| Browse: 34 \| Download: 93
2	Suppression of the STAT3/MYC/MCL-1 pathway by the fixed Jianpi Huoxue Formula relieves early biochemical abnormalities in liver fibrosis 8/18/2026 3:51:53 AM \| Browse: 49 \| Download: 215
3	Echoes of ancient wisdom and synergistic strategies invigorate the fight against liver fibrosis 6/30/2026 1:40:20 PM \| Browse: 83 \| Download: 310
4	Adipokine profiles reflect metabolic dysfunction but not fibrosis in patients with primary biliary cholangitis 2/12/2026 11:20:21 AM \| Browse: 161 \| Download: 767
5	Levodopa: A novel therapeutic prospect for liver disease 2/12/2026 11:20:20 AM \| Browse: 290 \| Download: 508
6	Should the theory of methotrexate-induced liver toxicity be abandoned? 2/12/2026 11:20:20 AM \| Browse: 246 \| Download: 519
7	Noninvasive liver fibrosis assessment in metabolic dysfunction-associated steatotic liver disease 1/27/2026 10:12:30 AM \| Browse: 264 \| Download: 386
8	Chrono-optimal treatments for human immunodeficiency virus/hepatitis C virus co-infection yield comparable survival outcomes with hepatitis C virus mono-infection 1/16/2026 11:31:19 AM \| Browse: 171 \| Download: 737
9	He-He-Shu-Yang formula alleviates liver fibrosis by inhibiting hepatic stellate cell activation in vivo and in vitro 12/26/2025 10:27:30 AM \| Browse: 172 \| Download: 619
10	Saffron and Calculus bovis combination exerts anti-hepatic fibrotic effect in liver fibrosis rats via the mitogen-activated protein kinases pathway 12/19/2025 10:39:43 AM \| Browse: 167 \| Download: 612
11	Advances in endoscopic ultrasound-guided shear wave elastography: A comprehensive review of its clinical applications 12/10/2025 7:48:07 AM \| Browse: 265 \| Download: 465
12	Levodopa and the dopamine receptor D1-Hippo/yes-associated protein axis: A novel therapeutic avenue for liver fibrosis 12/10/2025 7:48:07 AM \| Browse: 182 \| Download: 447
13	Non-invasive blood biomarkers for assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease 11/27/2025 7:53:54 AM \| Browse: 152 \| Download: 421
14	Real-world performance of transient elastography in assessing advanced fibrosis in Chinese patients with primary biliary cholangitis 11/6/2025 8:56:33 AM \| Browse: 261 \| Download: 856
15	Gray zone and the need for expansion in chronic hepatitis B: From theory to clinical practice 10/27/2025 10:57:50 AM \| Browse: 451 \| Download: 630
16	Nanoparticle-based systems for liver therapy: Overcoming fibrosis and enhancing drug efficacy 10/27/2025 10:57:49 AM \| Browse: 384 \| Download: 625
17	Revitalizing liver health: Human placental extract shows promise in chronic liver disease management 10/11/2025 9:30:02 AM \| Browse: 198 \| Download: 479
18	Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals 9/25/2025 11:24:03 AM \| Browse: 227 \| Download: 705
19	Machine learning fibrosis score for pediatric metabolic dysfunction-associated steatotic liver disease: Promising but premature 9/19/2025 7:57:22 AM \| Browse: 684 \| Download: 730
20	Dopamine receptor D1-mediated suppression of liver fibrosis via Hippo/Yes-associated protein 1 signaling in levodopa treatment 9/5/2025 6:36:19 AM \| Browse: 578 \| Download: 719
21	Dual therapy with vildagliptin and sacubitril/valsartan alleviates portal hypertension and inhibits soluble epoxide hydrolase in cirrhotic rats 9/1/2025 8:05:37 AM \| Browse: 726 \| Download: 758
22	Predictive value of core-fucosylated low-molecular-weight kininogen levels in patients with liver fibrosis: A prospective study 8/5/2025 8:25:49 AM \| Browse: 239 \| Download: 1049
23	Poor sleep and hepatic steatosis contribute to poorer quality of life in people with human immunodeficiency virus 8/5/2025 8:25:47 AM \| Browse: 323 \| Download: 883
24	Utility of splenic transient elastography in assessing for the presence of portal hypertension: A review 8/4/2025 12:11:34 PM \| Browse: 241 \| Download: 705
25	Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives 7/25/2025 12:09:44 PM \| Browse: 337 \| Download: 716
26	Role of mac-2 binding protein glycosylation isomer in predicting fibrosis in patients with metabolic dysfunction-associated steatotic liver disease 7/25/2025 12:09:41 PM \| Browse: 362 \| Download: 1008
27	FBP1 as a key regulator of focal adhesion kinase-mediated hepatic stellate cell activation: Multi-omics and experimental validation 7/24/2025 7:47:20 AM \| Browse: 334 \| Download: 887
28	Chronic hepatitis B with type 2 diabetes mellitus: Association between glycemic control and liver fibrosis 7/15/2025 8:26:32 AM \| Browse: 328 \| Download: 1063
29	Multiparametric ultrasound for non-invasive assessment of liver steatosis, fibrosis and inflammation in metabolic dysfunction-associated steatotic liver disease 7/4/2025 9:23:53 AM \| Browse: 331 \| Download: 947
30	Dietary ω-3 polyunsaturated fatty acid intake improves skeletal muscle mass in patients with metabolic dysfunction-associated fatty liver disease: A nationwide cross-sectional study 6/26/2025 7:27:57 AM \| Browse: 220 \| Download: 1076
31	Micro RNAs as a potential biomarker for predicting liver fibrosis severity in hepatitis C virus affected patients 6/23/2025 7:18:41 AM \| Browse: 376 \| Download: 1216
32	Advancing the diagnosis and treatment of metabolic-associated steatotic liver disease: The transformative role of artificial intelligence 6/6/2025 9:35:52 AM \| Browse: 161 \| Download: 700
33	Multi-parameter magnetic resonance imaging of zebularine in liver fibrosis treatment and calcineurin/NFAT3 mechanism 5/28/2025 7:32:59 AM \| Browse: 202 \| Download: 905
34	Sarcopenia and frailty: An in-depth analysis of the pathophysiology and effect on liver transplant candidates 5/27/2025 7:04:49 AM \| Browse: 361 \| Download: 773
35	Assessing the role of Mac-2 binding protein glycosylation isomer in the management of patients with chronic hepatitis B 5/27/2025 7:04:48 AM \| Browse: 394 \| Download: 1232
36	Quantification of Streptococcus salivarius using the digital polymerase chain reaction as a liver fibrosis marker 4/25/2025 8:23:06 AM \| Browse: 342 \| Download: 1059
37	Psoriasis, metabolic syndrome and methotrexate: Is this association suitable for a new subcategory in steatotic liver disease? 4/25/2025 8:23:02 AM \| Browse: 332 \| Download: 644
38	Global trends in artificial intelligence applications in liver disease over seventeen years 3/26/2025 4:06:51 AM \| Browse: 365 \| Download: 1254
39	Therapeutic potential of elafibranor in alcohol-associated liver disease: Insights into macrophage modulation and fibrosis reduction 3/5/2025 9:35:47 AM \| Browse: 234 \| Download: 711
40	Modern ultrasound techniques for diagnosing liver steatosis and fibrosis: A systematic review with a focus on biopsy comparison 2/20/2025 8:40:29 AM \| Browse: 256 \| Download: 904
41	Assessment of skeletal muscle alterations and circulating myokines in metabolic dysfunction-associated steatotic liver disease: A cross-sectional study 1/20/2025 7:38:55 AM \| Browse: 296 \| Download: 1054
42	Hepatitis B virus infection and metabolic dysfunction associated steatotic liver disease: Rising pandemic with complex interaction 1/6/2025 8:47:56 AM \| Browse: 262 \| Download: 752
43	Hotspots and trends in stem cell therapy for liver fibrosis and cirrhosis: A bibliometric analysis 1/6/2025 8:47:54 AM \| Browse: 275 \| Download: 1041
44	Elafibranor, a dual PPARα and PPARδ agonist, reduces alcohol-associated liver disease: Lessons from a mouse model 12/30/2024 6:47:30 AM \| Browse: 197 \| Download: 778
45	Red cell distribution width/platelet ratio predicts decompensation of metabolic dysfunction-associated steatotic liver disease related compensated advanced chronic liver disease 12/20/2024 3:53:49 AM \| Browse: 324 \| Download: 826
46	Elafibranor: A promising therapeutic approach for liver fibrosis and gut barrier dysfunction in alcohol-associated liver disease 12/20/2024 3:53:47 AM \| Browse: 389 \| Download: 839
47	Calculus bovis hijacks the tumor microenvironment in liver cancer cells in a multifaceted approach: A falling row of dominoes 11/29/2024 8:40:09 AM \| Browse: 249 \| Download: 1042
48	GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis 11/29/2024 8:40:08 AM \| Browse: 340 \| Download: 743
49	Elafibranor alleviates alcohol-related liver fibrosis by restoring intestinal barrier function 10/31/2024 10:42:49 AM \| Browse: 271 \| Download: 931
50	Encapsulating taurine into liposomes: A promising therapeutic for liver fibrosis 10/23/2024 4:32:16 AM \| Browse: 279 \| Download: 892